Amylyx Pharmaceuticals, Inc. (AMLX) Free cash flow 2021–2025
Amylyx Pharmaceuticals, Inc. (AMLX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$123.5MFY2025 · since FY2021: -$75.2M → -$123.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$123.5M | +26.4% |
| FY2024 | -$167.8M | -1671.5% |
| FY2023 | $10.7M | +105.9% |
| FY2022 | -$182.4M | -142.7% |
| FY2021 | -$75.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice